BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 205889)

  • 21. Cyclic nucleotide levels in the rat striatum and cerebellum--in vivo effects of dopamine and acetylcholine receptor agonists and antagonists.
    Puri SK; Choma P; Volicer L
    Biochem Pharmacol; 1978; 27(19):2333-6. PubMed ID: 215154
    [No Abstract]   [Full Text] [Related]  

  • 22. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding interactions of ergot alkaloids with monoaminergic receptors in the brain.
    Goldstein M; Lew JY; Hata F; Lieberman A
    Gerontology; 1978; 24 Suppl 1():76-85. PubMed ID: 22480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine receptor stimulating effects of chanoclavine analogues, tricyclic ergot alkaloids, in the brain.
    Watanabe H; Somei M; Sekihara S; Nakagawa K; Yamada F
    Jpn J Pharmacol; 1987 Dec; 45(4):501-6. PubMed ID: 3127619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ergot alkaloids inhibit 3H-naloxone binding to opiate receptors in the rat striatum and hippocampus.
    Kosar E; Sumová A; Jakoubek B
    Physiol Bohemoslov; 1986; 35(4):334-9. PubMed ID: 3020603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central monoamine synapses as sites of action for ergot drugs.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Hall H; Köhler C; Fredholm B
    Adv Biochem Psychopharmacol; 1980; 23():41-62. PubMed ID: 6104914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actions.
    Markstein R
    J Neural Transm; 1981; 51(1-2):39-59. PubMed ID: 6267192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolism.
    Markstein R; Herrling PL
    J Neurochem; 1978 Nov; 31(5):1163-72. PubMed ID: 702165
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
    Tonon G; Saiani L; Spano PF; Trabucchi M
    Brain Res; 1979 Jan; 160(3):553-8. PubMed ID: 217486
    [No Abstract]   [Full Text] [Related]  

  • 30. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
    Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Acta Endocrinol Suppl (Copenh); 1978; 216():27-56. PubMed ID: 347864
    [No Abstract]   [Full Text] [Related]  

  • 32. Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum.
    Saiani L; Trabucchi M; Tonon GC; Spano PF
    Neurosci Lett; 1979 Sep; 14(1):31-6. PubMed ID: 231228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Age-specific features of the cyclic nucleotide system in children].
    Bakanov MI
    Klin Lab Diagn; 1995; (3):20-2. PubMed ID: 8689048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of some ergot alkaloids on dopamine receptors of molluscan smooth muscle.
    Ishii Y; Takayanagi I
    J Pharmacobiodyn; 1982 Sep; 5(9):748-50. PubMed ID: 7153848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ergotamine and dihydroergotamine enhance guanylate cyclase activity.
    Vesely DL
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):245-54. PubMed ID: 6136069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the central effects of ergot alkaloids by means of electroencephalography.
    Longo VG; Loizzo A
    Pharmacology; 1978; 16 Suppl 1():189-92. PubMed ID: 643900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct effect of a nomifensine derivative on dopamine receptors.
    Poat JA; Woodruff GN; Watling KJ
    J Pharm Pharmacol; 1978 Aug; 30(8):495-7. PubMed ID: 28397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of bromocriptine on central dopaminergic receptors.
    Trabucchi M; Spano PF; Tonon GC; Frattola L
    Life Sci; 1976 Jul; 19(2):225-31. PubMed ID: 183071
    [No Abstract]   [Full Text] [Related]  

  • 39. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
    Corsini GU; Onali P; Masala C; Cianchetti C; Mangoni A; Gessa G
    Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.
    Prémont J; Tassin JP; Thierry AM; Bockaert J
    Adv Biochem Psychopharmacol; 1976; 15():347-56. PubMed ID: 192054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.